Clinical Trial Update: To Evaluate the Efficacy and Safety of 'NDTx-01' in Patients With ASD or SCD [NA]

View source ↗

Summary

Completed clinical trial evaluating the efficacy and safety of NDTx-01 in Autism Spectrum Disorder and Social Communication Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Social Communication Disorder

Drugs mentioned

• NDTx-01

Snippet

Sponsor: Neudive Inc. | Conditions: Autism Spectrum Disorder, Social Communication Disorder | NA | Status: COMPLETED